Abstract
The aim of the present study was to evaluate the effects of cyclosporin A (CyA) on the blood perfusion of the transplanted pancreas. For this purpose syngeneic pancreaticoduodenal transplantations were performed in Wistar-Furth rats. After nephrectomy the graft was anastomosed using a nonsuturing cuff technique to the left renal vessels. Beginning 7 days after transplantation and then continuing for 2 weeks, CyA (15 mg/kg body weight) or vehicle was given p.o. once daily, 6 days a week. The serum CyA concentrations were greater than 600 ng/ml at all points in time tested. Intraperitoneal glucose tolerance tests were normal in CyA-treated animals after 12 days, but the pancreatic insulin concentration was decreased to the same extent in the native and transplanted pancreas. A microsphere technique was used to measure the blood perfusion of the pancreaticoduodenal graft, the native pancreas and duodenum, and remaining kidney 14 days after starting the CyA treatment. The renal blood flow was markedly decreased by CyA when compared with the control animals. In rats given vehicle alone, pancreatic, islet, and duodenal blood flows were higher in the graft than in the corresponding native organs. However, in rats given CyA, hyperperfusion of the graft was not observed. We conclude that the administration of CyA prevents the transplantation-induced blood flow increase seen in pancreaticoduodenal grafts of vehicle-treated rats. These observations may reflect graft denervation.
Similar content being viewed by others
References
Abraham JS, Bentley FR, Garrison RN, Cryer HM (1991) The influence of the cyclosporine vehicle Cremophor EL on renal microvascular blood flow in the rat. Transplantation 52: 101–105
Andersson A, Borg H, Hallberg A, Hellerström C, Sandler S, Schnell A (1984) Long-term effects of cyclosporin A on cultured mouse pancreatic islets. Diabetologia 27: 66–69
Bani-Sacchi T, Bani D, Filipponi F, Michel A, Houssin D (1990) Immunocytochemical and ultrastructural changes of islet cells in rats treated long-term with cyclosporine at immunotherapeutic doses. Transplantation 49: 982–987
Benigni A, Perico N, Ladny JR, Imberti O, Bellizzi L, Remuzzi G (1991) Increased urinary excretion of endothelin-1 and its precursor, big-endothelin-1, in rats chronically treated with cyclosporine. Transplantation 52: 175–177
Bossaller C, Förstermann U, Hertel R, Olbricht C, Reschke V, Fleck E (1989) Cyclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production. Eur J Pharmacol 165: 165–169
Calne RY, White DJG, Evans DB, Thiru S, Henderson RG, Hamilton DV, Rolles K, McMaster P, Duffy TJ, MacDougall GRD, Williams R (1981) Cyclosporin A in cadaveric organ transplantation. BMJ 282: 934–936
Fan TPD, Lewis GP (1984) Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclooxygenase products in rat skin allografts. Br J Pharmacol 81: 361–371
Groen PC de (1989) Cyclosporine: a review and its specific use in liver transplantation. Mayo Clin Proc 64: 680–689
Gunnarsson R, Klintmalm G, Lundgren G, Wilczek H, Östman J, Groth CG (1983) Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet II: 571–572
Hahn HJ, Laube F, Lucke S, Klöting I, Kohnert KD, Warzok R (1986) Toxic effects of cyclosporine on the endocrine paucreas of Wistar rats. Transplantation 41: 44–47
Helmchen U, Schmidt WE, Siegel EG, Creutzfeldt W (1984) Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats. Diabetologia 27: 416–418
Henderson JM, Millikan WJ, Hooks M, Noe B, Kutner MH, Warren WD (1989) Increased galactose clearance after liver transplantation: a measure of increased blood flow through the denervated liver? Hepatology 10: 288–291
Jansson L, Hellerström C (1983) Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25: 45–50
Jansson L, Eizirik DL, Sandler S (1989) Terbutaline decreases the blood flow of the pancreatic islets but does not reduce the diabetogenic action of streptozotocin in the rat. Eur J Pharmacol 161: 79–83
Jansson L, Korsgren O, Wahlberg J, Andersson A (1992) Pancreatic islet blood flow after syngeneic pancreatico-duodenal transplantation in rats. Differences in the blood perfusion between the native and the transplanted gland. Transplantation 53: 517–521
Jennings WC, Corry RJ (1990) Vascular response to cyclosporine and verapamil in the rat pancreas. J Surg Res 49: 341–343
Kahan BD, Ried M, Newburger J (1983) Pharmacokinetics of cyclosporine in human renal transplantation. Transplant Proc 15: 446–448
Kawaguchi W, Goldman MN, Shapiro R, Foegh ML, Ramwell PW, Lower RR (1985) Increase in urinary thromboxane A2 in rats caused by cyclosporine. Transplantation 40: 214–216
Klintmalm GB, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporine A in liver and kidney transplant recipients. Lancet I: 470–471
Moss NG, Powell SL, Falk RJ (1985) Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 82: 8222–8226
Müller MK, Bergmann K, Degenhardt H, Klöppel G, Löhr M, Coone HJ, Goebell H (1988) Differential sensitivity of rat exocrine and endocrine pancreas to cyclosporine. Transplantation 45: 698–700
Murray BM, Paller MS (1986) Beneficial effects of renal denervation and prazocin on GFR and renal blood flow after cyclosporine in rats. Clin Nephrol 25 [Suppl 1]: S37-S39
Nagineni C, Misra BC, Lee DBN, Yanagawa N (1987) Cyclosporine calcium channel interaction: a possible mechanism for nephrotoxicity. Transplant Proc 19: 1358–1360
Nussenblatt RB, Rodrigues MM, Levario SS, Salinas-Carmona MC (1981) Cyclosporin A: inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest 67: 1228–1231
Olausson M, Mjörnstedt L, Lindholm L, Brynger H (1984) Nonsuture organ grafting to the neck vessels in rats. Acta Chir Scand 150: 463–466
Otsu I, Kitano N, Taminato T, Fujiya H, Nozawa M (1987) Cyclosporine A toxicity for vascularized pancreatic transplantation in the rat. Transplant Proc 19: 1252–1256
Parkhurst GW, Prancan AV, Moon BH (1991) Alpha adrenergic antagonism by cyclosporine. Transplantation 51: 1080–1084
Pipeleers DG, Marichal P (1978) Secretory capability of islets transplanted intraportally in the diabetic rat. Diabetes 27: 817–821
Remuzzi G, Bertani I (1989) Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 13: 261–272
Rooth P, Dawidson I, Diller K, Täljedal I-B (1988) Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice. Transplantation 45: 433–437
Stiller CR, Laupacis A, Dupre J, Jenner MR, Keown PA, Rodger RA, Wolff BMJ (1983) Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med 308: 1226–1227
Sumpio B, Baue A, Chaudry IH (1987) Alleviation of cyclosporine nephrotoxicity with verapamil and ATP-MgCl2. Ann Surg 204: 655–670
Sundler F, Böttcher G (1991) Islet innervation with special reference to neuropeptides. In: Samols E (ed) The endocrine pancreas. Raven Press, New York, pp 29–52
Tiscornia OM (1978) The neural control of the exocrine and endocrine pancreas. Am J Gastroenterol 67: 541–560
Vladutio AO (1983) Effect of cyclosporine on experimental autoimmune thyroiditis in mice. Transplantation 35: 518–520
Wagner K, Albrecht S, Neumayer HH (1987) Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study. Am J Nephrol 7: 287–293
Wahlberg J, Love R, Ladegaard L, Southard JH, Belzer FO (1987) 72 hour preservation of the canine pancreas. Transplantation 43: 5–8
Wassef R, Cohen Z, Langer B (1985) Pharmacokinetic profiles of cyclosporine in rats. Transplantation 40: 489–493
Weil C (1984) Cyclosporin A: review of results in organ and bone marrow transplantation in man. Med Res Rev 4: 221–265
White TP, Maxwell LC, Sosin DM, Faulkner JA (1981) Capillarity and blood flow of transplanted skeletal muscle of cats. Am J Physiol 241: H630-H635
Yale JF, Roy RD, Grose M, Seemayer TA, Murphy GF, Marliss EB (1985) Effects of cyclosporine on glucose tolerance in the rat. Diabetes 34: 1309–1313
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yasaki Y, Goto K, Yasaki K (1988) A novel potent vasocontrictor peptide produced by vascular endothelial cells. Nature 332: 441–415
Youngelman DF, Kahng KU, Dresner LS, Munshi IA, Wait RB (1991) Cyclosporine-induced alterations in renal, intrarenal, and pancreatic blood flow. Transplant Proc 23: 718–720
Author information
Authors and Affiliations
About this article
Cite this article
Jansson, L., Korsgren, O., Wahlberg, J. et al. Effects of cyclosporin A on the blood flow of the native and transplanted rat pancreas and duodenum. Transpl Int 6, 143–147 (1993). https://doi.org/10.1007/BF00336357
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00336357